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SUMMARY: Objectives: We present the results of treatment by laparoscopy of two patients with retroperitoneal fibrosis and
review the literature since 1992, when the first case of this disease that was treated using laparoscopy was published. We also discuss
the contemporary alternatives of clinical treatment with corticosteroids and tamoxifen.
Case report: Two female patients, one with idiopathic retroperitoneal fibrosis, and other with retroperitoneal fibrosis associated
with Riedel’s thyroiditis, were treated using laparoscopic surgery. Both cases had bilateral pelvic ureteral obstruction and were
treated using the same technique: transperitoneal laparoscopy, medial mobilization of both colons, liberation of both ureters from
the fibrosis, and intraperitonealisation of the ureters. Double-J catheters were inserted before the operations and removed 3 weeks
after the procedures. The first patient underwent intraperitonealisation of both ureters in a single procedure. The other had 2 different
surgical procedures because of technical difficulties during the first operation. Both patients were followed for more than 1 year and
recovered completely from the renal insufficiency. One of them still has occasional vague lumbar pain. There were no abnormalities
in the intravenous pyelography in either case.
Conclusions: Surgical correction of retroperitoneal fibrosis, when indicated, should be attempted using laparoscopy. If possible,
bilateral ureterolysis and intraperitonealisation of both ureters should be performed in the same operation.
DESCRIPTORS: Retroperitoneal fibrosis.  Ureteral intraperitonealisation. Ureterolysis.
Retroperitoneal fibrosis was first
described by French urologist Albarran
at the beginning of the century and has
received countless other names through
time: Ormond’s disease, fibrotic peri-
ureteritis, plastic periureteritis, chronic
periureteritis, sclerosing retroperitoneal
granuloma, fibrotic retroperitonitis,
perianeurismatic retroperitoneal fibro-
sis, subclinical chronic periaortitis, and
chronic periaortitis1,2. Until recently,
different etiopathogenic conditions
were grouped under the name of ret-
roperitoneal fibrosis which generated
confusion in medical literature. Current
practice is to classify retroperitoneal fi-
brosis into 2 groups: idiopathic and
secondary1. Idiopathic retroperitoneal
fibrosis (IRF), which comprises to two-
thirds of the total cases, is retroperito-
neal fibrosis in which no etiology can
be defined and that does not associate
itself to any other etiopathogenic con-
dition (Table 1). Secondary retroperi-
toneal fibrosis (SRF) is associated with
cancer, drugs, chemical products, in-
fections, inflammatory diseases, retro-
peritoneal bleeding, or radiotherapy1.
IRF afflicts all races equally, being
predominant in the male sex in the pro-
portion of 2:1 to 3:1, with its peak of
incidence being between 40 and 60
years of age4. There is evidence that the
onset of IRF depends on hereditary
predisposition, and may have an etio-
logic relation with the arteriosclerotic
process of the terminal aorta and the
iliac arteries1,5,6. IRF has an initially in-
sidious and vague clinical presentation
with symptoms being malaise, lumbar
pain, anorexia, low fever, and asthenia.
Of these, the most frequent, which
must therefore be emphasized, is lum-
bar pain, which is present in 80% to
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90% of the cases; however, this symp-
tom is not diagnostic. With the evolu-
tion of the disease, manifestations in-
dicative of renal insufficiency due to
bilateral ureteral compression, such as
hypertension, edema and anemia, or
even signs caused by the compression
of retroperitoneal veins, such as edema
of the lower limbs, varicocele, and hy-
drocele1,4 may appear. Diagnosis of
IRF in its initial phase is very difficult
because the physical examination of
the patient is usually normal and the
clinical laboratory findings are nonspe-
cific, the most constant being the eleva-
tion of ESR (erythrocyte sedimentation
rate) present in over 80% of the cases.2
The clinical diagnosis depends funda-
mentally on the demonstration, by
computerized tomography (CT) or,
preferably, magnetic nuclear resonance
(MRI) 7, of a unilateral, or, far more
frequently, bilateral thickening of the
retroperitoneum, which may extend
vertically from the renal hilum to the
pelvic brim, and laterally from one
psoas muscle to the other. In the ma-
jority of cases, the fibrotic retroperito-
neal thickening is located between the
last lumbar vertebrae and the first sac-
ral vertebrae, in the region of the aor-
tic bifurcation, sparing the posterior
region of the great vessels. The medial
deviation of the ureters in their middle
portion is typical, however non-pathog-
nomonic, as is the approximation of
the aorta and the vena cava, in opposi-
tion to what occurs in malignant meta-
static diseases, in which augmented
interaortocaval lymph nodes promote
distancing of the great vessels8.
The treatment of IRF is controver-
sial, not only because the natural his-
tory of the disease is not well known
due to its low incidence, estimated by
some to be 1/200 000 inhabitants9, but
also because there are reports of spon-
taneous regression10 and favorable re-
sponses to several different pharmaceu-
tical treatments with corticosteroids,
tamoxifen, azatioprin, methotrexate,
cyclophosfamide, and penicillamine,
used alone or in combination, with or
without concomitant use of Double-J
ureteral catheters1,11. Unfortunately, all
reports of clinical treatment involve
small numbers of patients and are not
controlled studies; for this reason,
many urologists, claiming good results
in the long run, have opted for imme-
diate surgical treatment, once the diag-
nosis is established1,2,5,12. Surgical treat-
ment consists basically in unilateral or
bilateral ureterolysis. Some defend bi-
lateral treatment in all cases, even if
there are no radiological evidences of
involvement of both ureters.1 The ure-
terolysis is the liberation of all the in-
carcerated portion of the ureter, which
is usually involved by a circular con-
centric fibrosis, from its proximal
healthy portion to the distal portion,
generally free of fibrosis, below the
iliac vessels. The ureteral liberation, as
an isolated procedure, can lead to re-
lapse, hence the preference of the ma-
jority of surgeons for wrapping the ure-
ters with retroperitoneal fat or greater
omentum, or, alternatively, intra-
peritonealisation them1,2,9. Whenever
possible, whether to alleviate renal in-
sufficiency, reducing the risk of com-
plications, or to facilitate the ureteral
identification and dissection, a Double-
J catheter is introduced in each of the
ureters, days or weeks before surgery,
remaining there for 2 to 3 weeks after
surgery9.
Open surgery has been traditionally
performed through a median trans-
peritoneal incision. Some prefer open-
ing the retroperitoneum through a me-
dian incision in the posterior perito-
neum, beginning superiorly between
the duodenum and the inferior mesen-
teric vein, others opt to incise the line
of Toldt, mobilizing the colons medi-
ally1,2.  Both retroperitoneal approaches
allow ureterolysis, the envelopment of
the ureters with fatty tissue followed by
intraperitonealisation. The open sur-
gery has approximately 9% mortality
and 60% morbidity, either because the
patients frequently present chronic re-
nal insufficiency and poor clinical con-
ditions, or because of the extent of the
surgery9.
When possible, the underlying dis-
ease of SRF is treated. When this is not
possible, the clinical or surgical treat-
ment for IRF can be performed, with
similar results2,9,12.
Since 1992, several cases of
laparoscopic ureterolysis and
intraperitonealisation have been de-
scribed, with low morbidity rates and
no deaths reported9,13-18. Elashry, et al
compared the results of 6 laparoscopic
surgeries with 7 open surgeries, all uni-
lateral ureterolysis cases, and con-
cluded that the laparoscopic approach
is superior in all considered aspects,
with the only exception being mean
surgical time: 255 minutes for the
laparoscopy versus 232 minutes for the
open surgery9. Because of these reports
and our previous experience with
laparoscopic technique, we decided to
evaluate the results of laparoscopic
intraperitonealisation in retroperitoneal
fibrosis cases and also review the
medical information related to the
treatment of retroperitoneal fibrosis.
Table 1 - Retroperitoneal fibrosis:
etiology in 491 patients*
Etiology Percent
Idiopathic 67.8
Methysergide 12.4
Malignancies 7.9
Mediastinal fibrosis 3.3
Periaortic inflammation 2.4
Mesenteric fibrosis 2.0
Sclerosing cholangitis 1.6
Aortic abdominal aneurism 1.6
Crohn’s disease 1.2
Thrombophlebitis 1.0
Riedel’s thyroiditis 0.8
Other 5.3
* Modified from Koep & Zuidema 3
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CASE REPORTS
Surgical technique
The patient undergoing single-stage
bilateral intraperitonealisation of the
ureters lies on the operating table in
dorsal decubitus, with arms extended
alongside the body, under general an-
esthesia. Initially, only 4 trocars are
used, but more may be inserted de-
pending on the difficulty of the surgery
and the extent of the ureteral fibrosis.
The trocars are inserted in the abdomen
based on the extent of the intended dis-
section. In bilateral intraperitoneali-
sation with ureteral segments incarcer-
ated in the sacrolumbar area, a 10 mm
trocar is inserted through the umbilical
scar (for the optic), a 5 mm trocar is
inserted in the hemiclavicular line on
each side, 2-3 centimeters below the
umbilical scar, and a 10/11mm trocar
is inserted in the median line, 2 cm
above the pubis. Once the trocars are
inserted and the cavity is inspected, the
procedure begins.
An incision in the parietal perito-
neum is made laterally to the line of
Toldt, so as to leave a 2 cm free peri-
toneum band connected to the colon,
to be later sutured or clipped to the lat-
eral border of the peritoneum. The co-
lon is mobilized medially (which side
first is irrelevant), to expose the
Gerota’s fascia and the ureter. The
healthy ureteral segment, distal or
proximal, is approached first and
placed under light traction with a thin
Penrose drain to facilitate the dissec-
tion. The presence of a Double-J cath-
eter inserted prior to surgery greatly
diminished the difficulty of this ma-
neuver. The incarcerated segment of
the ureter is dissected and freed from
the fibrosis in its full extent until the
normal portion of the ureter is reached
(either proximal or distal). Once mo-
bilized, the ureteral segment is placed
anteriorly to the borders of the incised
parietal peritoneum, which are ap-
proximated with sutures or metallic
clips, depending on the availability of
the material and the surgeon’s prefer-
ence. Care is taken not to leave the ure-
ter angled or narrowed in the entrances
to the retroperitoneum, proximally and
distally. The procedure is repeated in
the contralateral side, and the surgery
is finalized. Both ureteral catheters are
removed 3 weeks after the surgery.
Two patients with retroperitoneal
fibrosis who had been sent for bilateral
intraperitonealisation through laparo-
tomy were selected for laparoscopic
surgery. After the informed consent of
both, the surgeries were performed.
Case 1
G.P.N., white female, 58 years old,
born in Piatá (BA), went to the ER of
the Hospital das Clinicas da FMUSP in
April 1996 with intermittent bilateral
lumbar colics, and occasional fever.
She had antecedents of idiopathic hy-
pothyroidism, arterial hypertension,
and diabetes mellitus, adequately
treated. At this occasion, her physical
examination was normal. She under-
went routine clinical laboratory tests,
which were all normal, except for se-
rum creatinine (C=2.0). She then took
an abdominal echography, revealing
bilateral ureterohydronephrosis. Then,
under local anesthesia, a retrograde bi-
lateral ureteropyelography was per-
formed; its result was suggestive of ex-
trinsic ureteral obstruction (L4-L5 re-
gion), with medial deviation of the ure-
ters in their middle portions. In the
same procedure, Double-J catheters
were introduced bilaterally with no dif-
ficulties. After a few weeks, serum
creatinine fell to 1.2, and the patient
did not present further complaints. The
CT revealed a thickening of the
retroperitoneum anterior to the great
vessels, between L4 and S1, suggest-
ing retroperitoneal fibrosis (Fig. 1). On
7-30-1996 the laparoscopic bilateral
ureteral intraperitonealisation was per-
formed.
The surgical procedure took 3
hours and 35 minutes, and there were
no intra or post-operative complica-
tions. Bleeding was negligible. The pa-
tient was discharged on the 3rd post-
operative day, reporting practically no
pain. The catheters were removed 3
weeks after the surgery, and a bilateral
pyelography was performed to visual-
ize the ureters (Fig. 2). She was then
Figure 1 - Abdominal CT shows a retroperitoneal thickening anterior to the great vessels, and bilateral
hydronephrosis.
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Figure 4 - Normal intravenous pyelography 1 year after the operation.
Figure 2 - Left retrograde ureteropyelography 4 weeks after the operation.
One can observe pyeloureteral ectasy and an exaggerated ureteral
lateralization. On the right side the image was similar.
Figure 3 - Intravenous pyelography 3 months after the operation. One can
observe pyeloureteral ectasy, mainly on the left side.
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followed with serum creatinine and in-
travenous pyelographies. The creati-
nine stabilized at 1.3 and the pyelog-
raphies 1 and 2 years after the surgery
showed normal kidneys, absence of di-
lation, and ureteral lateralization (Figs.
3 and 4). The patient reports light lum-
bar pain on the right side, irradiated to
the right inferior limb, which ceases
with common analgesics.
Case 2
J.A.A., white female, 51 years old,
born in Guararapes (SP), presented a
sudden increase in the anterior cervi-
cal region, with fever and sweating, in
October, 1996. Initially treated with
antiinflammatories and antibiotics, she
underwent clinical laboratory tests until
February, 1997, when the diagnosis of
hypothyroidism was established and
the treatment with T3 and T4 initiated.
In 1997, she presented bilateral lumbar
pain and dysuria. Her physical exami-
nation at the occasion had a single ab-
normality: augmented thyroid with pe-
trous consistency. The abdominal
echography revealed bilateral uretero-
hydronephrosis. Serum creatinine was
4.4, and the CT was suggestive of ret-
roperitoneal fibrosis. On 9-26-1997, an
attempt to pass Double-J catheters bi-
laterally was unsuccessful, and two
thin ureteral catheters externally con-
nected to a Foley catheter were left in
place. Two weeks later it was possible
to substitute each catheter for a
Double-J. On the 10-21-1997, the pa-
tient underwent a laparoscopic proce-
dure for retroperitoneal biopsies and
bilateral ureteral intraperitonealisation.
The ureterolysis of the left side was
easy, and the intraperitonealisation was
completed. However, on the right side,
the fibrotic process was far more in-
tense and did not allow the identifica-
tion of the ureter or of the iliac vessels.
Four hours after the start of the surgery,
the choice was made for a direct ure-
terolysis on another occasion. In the
same anesthetic session, a thyroid bi-
opsy was performed, confirming clini-
cal suspicion of Riedel’s thyroiditis.
The retroperitoneal biopsies revealed
only an unspecific inflammatory pro-
cess. The patient was discharged on the
10th post-operative day, with no com-
plications. There was no need for blood
transfusion. The late discharge was due
to social problems of the patient; clini-
cally, she could have left the hospital
on the 2nd or 3rd post-operative day.
Due to the extensive fibrosis on the
right side, involving not only the ure-
ter but also the psoas muscle and the
iliac vessels, treatment with prednisone
(40 mg/day) and tamoxifen (20 mg/
day) for 3 months was initiated. On the
02-09-98, the patient successfully un-
derwent laparoscopic ureterolysis and
intraperitonealisation on the right side.
During the surgery, it was observed
that the fibrosis extended up to the re-
nal fossa. The renal pelvis was acciden-
tally opened and closed with an
intracorporeal suture using chromic
catgut 4-0.
In this case, the first surgery took
4 hours; the second, 3 hours and 15
minutes. Bleeding was negligible in
both procedures, and the patient was
discharged in the 10th and 5th post-op-
erative day, respectively. Both ureteral
catheters were removed three weeks
after the second surgery. After a year
of follow-up, the patient had no ab-
dominal or lumbar pain, serum creati-
nine stabilized at 1.4 and the intrave-
nous pyelography was normal.
In none of the 3 procedures was
any form of drainage used in the ab-
dominal cavity.
DISCUSSION
Due to the relative rarity of retro-
peritoneal fibrosis, there are few re-
ports in medical literature that present
more than a dozen cases originated in
the same service, and even then, these
are non-randomized and lack control
groups. The reports with the greatest
data are usually product of literature
reviews and suffer from the same limi-
tations4. In face of available published
data, it can be said that not much is
known yet about the natural history of
retroperitoneal fibrosis, nor about the
most appropriate treatment for patients.
It is also impossible to determine
where clinical treatment attempts
should end and in which circumstances
should surgical treatment begin. There
are those who defend the superiority of
clinical treatments11, and those who
choose surgery as the best option5,12;
however, in neither case is there rigor-
ous scientific basis. Due to the good
results obtained by some with corticoid
treatment, in doses (determined empiri-
cally) of 20 to 60 mg of prednisone a
day during several weeks, or with
tamoxifen, 20 mg a day during several
months (dosage also determined em-
pirically), and eventually used in asso-
ciation, it can be argued that the clini-
cal treatment should be primarily at-
tempted in IRF and in some forms of
SRF11. Tamoxifen, used in IRF since
199119, has intense antiestrogenic ac-
tion, and its usefulness in breast can-
cer is beyond question. However, even
in cases where there are no estrogenic
receptors, tamoxifen seems to work,
inhibiting the proliferation of fibro-
blasts, hence its utilization in fibrotic
diseases and mesenchymal tumors20-23.
In non-malignant IRF and SRF, ret-
roperitoneal biopsies can reveal differ-
ent degrees of inflammatory cellularity,
which suggests different stages in the
fibrotic formation process. Theoreti-
cally, the greater the cellularity, the
greater the probability of corticoids re-
verting the process and avoiding the fi-
brosis. Once the fibrosis is established
in greater or lesser degree, tamoxifen
seems to have some effect, hence the
theoretical utility of the combined use
of corticosteroids and tamoxifen in
cases in which the pathology demon-
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strates high degree of inflammatory
cellularity, or only tamoxifen, when the
fibrosis is predominant. As a way to
optimize the clinical treatment, system-
atic biopsies to ascertain non-malig-
nancy and also to determine the degree
of inflammatory cellularity has been
suggested by some clinicians. Others
suggest treatment with corticosteroids
in the post-operative period2,5,20,23.
Not all cases respond to clinical
treatment; these must treated surgically.
Open surgery has significant morbidity
and mortality1,9. Since 1992,
laparoscopic technique has been suc-
cessfully performed by some groups,
with results apparently comparable to
those of open surgery, but having lower
incidence of complications with no
deaths reported due to the surgical pro-
cedure13. In the treatment of unilateral
ureteral incarceration, Elashry et al9 con-
cluded that laparoscopic surgery was
superior to open surgery, despite requir-
ing a few more minutes on average to
perform. His study compared 6 cases of
unilateral fibrosis, only 2 of which hav-
ing an IRF diagnosis, with 7 historical
cases of fibrosis, also unilateral, 2 of
which were associated with aortic aneu-
rysms and 1 with a total hysterectomy.
His conclusions can be questioned, as
they are based on a small data set, non-
comparable groups, and a majority of
SRF cases. Although there are no
groups with large experience in
laparoscopically corrected SRF yet,
those that have performed it have had
the impression, based also on the expe-
rience of successful laparoscopic treat-
ment of other retroperitoneal diseases,
such as adrenalectomy and nephrec-
tomy, that laparoscopy is the method of
choice in retroperitoneal fibrosis.
Ureterolysis, performed as an iso-
lated procedure, probably has more fre-
quent recurrences, which is why most
surgeons perform the complimentary
ureteral intraperitonealisation, with or
without involvement of greater omen-
tum, with superior results. Some proceed
empirically with pharmaceutical treat-
ment after successful surgery as prophy-
laxis of recurrence1, 2, 5, 11. Some investi-
gators have also empirically determined
that the Double-J catheters must remain
for 2 to 3 weeks after surgery.
In the two patients we had the op-
portunity to treat and follow, we made
no attempt to treat primarily with cor-
ticosteroids and/or tamoxifen before
prescribing surgery, because these
cases were initially considered ad-
vanced and had already been selected
for open surgery by other colleagues.
However, considering the international
experience with clinical treatment, to-
day the handling of the cases could
have possibly been different. After the
Double-J catheters had been passed,
we would have attempted a clinical
treatment with corticosteroids and
tamoxifen for 3 or 4 weeks, and then
reevaluated. In case of regression of the
fibrosis, verified by CT or MRI, we
would proceed for a few more weeks
and then decide on whether to operate,
based on the results. The empirical
clinical treatment introduced in the sec-
ond case, after the failed attempt to per-
form the ureterolysis on the right side,
was not adequately evaluated, making
conclusions unfeasible. The subjective
intra-operative impression was of a
slightly diminished fibrosis, which fa-
cilitated the dissection of the pelvic
ureter, impossible in the first operation.
The association of retroperitoneal
fibrosis with Riedel’s thyroiditis, as in
our second case, is very rare, and does
not require any special therapeutic
measure in the approach of retroperi-
toneal fibrosis3,24,25. Despite being etio-
logically classified as SRF, the patient
was successfully treated as IRF.
The clinical evolution in both cases
was excellent, the painful symptoms
and the renal insufficiency having dis-
appeared rapidly. However, the radio-
logical evolution was slower, with
pyeloureteral ectasy persisting for sev-
eral months (Fig. 3). After a year of
evolution, the radiologic images nor-
malized completely in both cases, even
though signs of retroperitoneal fibrosis
persisted (Fig. 4).
In conclusion, although we do not
yet know much about retroperitoneal
fibrosis, its natural history, or the best
treatment alternatives, when there is
surgical indication, we understand that
the laparoscopic intraperitonealisation
is possibly the most appropriate tech-
nique for the patient, which may be
confirmed in the next few years.
RESUMO RHCFAP/3006
CASTILHO L N e col. - Tratamento
laparoscópico de fibrose retroperito-
neal: relato de dois casos e revisão
da literatura. Rev. Hosp. Clín. Fac.
Med. S. Paulo 55(2):69-76, 2000.
Objetivos: Os autores apresentam
os resultados de dois pacientes com
fibrose retroperitoneal tratados por
laparoscopia e fazem a revisão da litera-
tura desde 1992, quando o primeiro caso
de fibrose retroperitoneal tratado lapa-
roscopicamente foi publicado. Eles tam-
bém discutem as alternativas terapêuticas
contemporâneas de tratamento clínico
com corticosteróides e tamoxifeno.
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Relato dos casos: Duas mulheres,
uma com fibrose retroperitoneal
idiopática, e a outra com fibrose
retroperitoneal associada a tireoidite
de Riedel, foram operadas por
laparoscopia. Ambas apresentavam
obstrução ureteral pélvica bilateral e
foram operadas por meio da mesma
técnica: laparoscopia transperitoneal,
mobilização medial de ambos os có-
lons, liberação dos ureteres da fibrose
e intraperitonização ureteral. Cateteres
Duplo-J foram inseridos antes das ci-
rurgias e removidos três semanas de-
pois da intraperitonização. A primei-
ra paciente teve os dois ureteres
intraperitonizados em um único pro-
cedimento. A segunda foi submetida
a dois procedimentos distintos por di-
ficuldades técnicas durante a primei-
ra cirurgia. Ambas foram acompanha-
das por mais de um ano e recupera-
ram-se completamente da insuficiên-
cia renal. Uma delas ainda tem dor
lombar leve ocasionalmente. As
urografias excretoras de ambas as pa-
cientes não apresentam mais anorma-
lidades.
Conclusões: A correção cirúrgica
da fibrose retroperitoneal, quando
indicada, deve ser realizada por lapa-
roscopia. A ureterolise e a intra-
peritonização de ambos os ureteres
devem ser realizadas no mesmo ato
cirúrgico, sempre que possível.
DESCRITORES:  Fibrose retro-
peritoneal.   Intraperitonização ure-
teral.   Ureterolise.
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